Amyloid formation of a protein in the absence of initial unfolding and destabilization of the native state

Biophysical Journal

Volumn 89, Issue 6, 2005, Pages 4234-4244

  Soldi, Gemma ^a   Bemporad, Francesco ^a   Torrassa, Silvia ^b   Relini, Annalisa ^b   Ramazzotti, Matteo ^a   Taddei, Niccolò ^a   Chiti, Fabrizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 ANILINO 1 NAPHTHALENESULFONIC ACID; ACYLPHOSPHATASE; AMYLOID; CONGO RED; PROTEIN ACPDRO2; THIOFLAVINE; TRIFLUOROETHANOL; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; BETA SHEET; CATALYSIS; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; DROSOPHILA MELANOGASTER; ENZYME ACTIVITY; FLUORESCENCE; HYDRODYNAMICS; KINETICS; LIGHT SCATTERING; NONHUMAN; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN STRUCTURE;

DROSOPHILA MELANOGASTER;

EID: 28444464509     PISSN: 00063495     EISSN: 00063495     Source Type: Journal    
DOI: 10.1529/biophysj.105.067538     Document Type: Article

References (50)

1. Dobson, C. M. 2003. Protein folding and misfolding. Nature. 426:884-890.
2. Stefani, M., and C. M. Dobson. 2003. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81:678-699.
3. Uversky, V. N., and A. L. Fink. 2004. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta. 1698:131-153.
4. Walsh, D. M., and D. J. Selkoe. 2004. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept. Lett. 11:213-228.
5. Sunde, M., and C. Blake. 1997. The structure of amyloid fibrils by electron microscopy and x-ray diffraction. Adv. Protein Chem. 50:123-159.
6. Serpell, L. C., M. Sunde, M. D. Benson, G. A. Tennent, M. B. Pepys, and P. E. Fraser. 2000. The protofilament substructure of amyloid fibrils. J. Mol. Biol. 300:1033-1039.
7. Tycko, R. 2003. Insights into the amyloid folding problem from solid-state NMR. Biochemistry. 42:3151-3159.
8. Klunk, W. E., R. F. Jacob, and R. P. Mason. 1999. Quantifying amyloid by Congo red spectral shift assay. Methods Enzymol. 309:285-305.
9. LeVine 3rd, H. 1999. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309:274-284.
10. Krebs, M. R., E. H. Bromley, and A. M. Donald. 2005. The binding of thioflavin-T to amyloid fibrils: localisation and implications. J. Struct. Biol. 149:30-37.
11. Khurana, R., V. N. Uversky, L. Nielsen, and A. L. Fink. 2001. Is Congo red an amyloid-specific dye? J. Biol. Chem. 276:22715-22721.
12. Bousset, L., V. Redeker, P. Decottignies, S. Dubois, P. Le Marechal, and R. Melki. 2004. Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p. Biochemistry. 43:5022-5032.
13. Chow, M. K., H. L. Paulson, and S. P. Bottomley. 2004. Destabilization of a non-pathological variant of ataxin-3 results in fibrillogenesis via a partially folded intermediate: a model for misfolding in polyglutamine disease. J. Mol. Biol. 335:333-341.
14. Lindberg, M. J., L. Tibell, and M. Oliveberg. 2002. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: decreased stability of the apo state. Proc. Natl. Acad. Sci. USA. 99:16607-16612.
15. Canet, D., A. M. Last, P. Tito, M. Sunde, A. Spencer, D. B. Archer, C. Redfield, C. V. Robinson, and C. M. Dobson. 2002. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nat. Struct. Biol. 9:308-315.
16. Kelly, J. W. 1998. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8:101-106.
17. Rochet, J. C., and P. T. Lansbury, Jr. 2000. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10:60-68.
18. Chow, M. K., A. M. Ellisdon, L. D. Cabrita, and S. P. Bottomley. 2005. Polyglutamine expansion in Ataxin-3 does not affect protein stability: implications for misfolding and disease. J. Biol. Chem. 279:47643-47651.
19. Bouchard, M., J. Zurdo, E. J. Nettleton, C. M. Dobson, and C. V. Robinson. 2000. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 9:960-967.
20. Pedersen, J. S., G. Christensen, and D. E. Otzen. 2004. Modulation of S6 fibrillation by unfolding rates and gatekeeper residues. J. Mol. Biol. 341:575-588.
21. Plakoutsi, G., N. Taddei, M. Stefani, and F. Chiti. 2004. Aggregation of the acylphosphatase from Sulfolobus solfataricus: the folded and partially unfolded states can both be precursors for amyloid formation. J. Biol. Chem. 279:14111-14119.
22. Degl'Innocenti, D., M. Ramazzotti, R. Marzocchini, F. Chiti, G. Raugei, and G. Ramponi. 2003. Characterization of a novel Drosophila melanogaster acylphosphatase. FEBS Lett. 535:171-174.
23. Zuccotti, S., C. Rosano, M. Ramazzotti, D. Degl'Innocenti, M. Stefani, G. Manao, and M. Bolognesi. 2004. Three-dimensional structural characterization of a novel Drosophila melanogaster acylphosphatase. Acta Crystallogr. D Biol. Crystallogr. 60:1177-1179.
24. Camici, G., G. Manao, G. Cappugi, and G. Ramponi. 1976. A new synthesis of benzoyl phosphate: a substrate for acyl phosphatase assay. Experientia. 32:535-536.
25. Johnson, W. C., Jr. 1990. Protein secondary structure and circular dichroism: a practical guide. Proteins. 7:205-214.
26. Ramponi, G., C. Treves, and A. A. Guerritore. 1966. Aromatic acyl phosphates as substrates of acyl phosphatase. Arch. Biochem. Biophys. 115:129-135.
27. Santoro, M. M., and D. W. Bolen. 1988. Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenyl-methanesulfonyl alpha-chymotrypsin using different denaturants. Biochemistry. 27:8063-8068.
28. Jackson, S. E., and A. R. Fersht. 1991. Folding of chymotrypsin inhibitor 2. 1. Evidence for a two-state transition. Biochemistry. 30:10428-10435.
29. Venyaminov, S. Yu., and K. S. Vassilenko. 1994. Determination of protein tertiary structure class from circular dichroism spectra. Anal. Biochem. 222:176-184.
30. Relini, A., C. Canale, S. Torrassa, R. Rolandi, A. Gliozzi, C. Rosano, M. Bolognesi, G. Plakoutsi, M. Bucciantini, F. Chiti, and M. Stefani. 2004. Monitoring the process of HypF fibrillization and liposome permeabilization by protofibrils. J. Mol. Biol. 338:943-957.
31. Stryer, L. 1965. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites. J. Mol. Biol. 13:482-495.
32. Ptitsyn, O. B. 1995. Molten globule and protein folding. Adv. Protein Chem. 47:83-229.
33. Matulis, D., and R. Lovrien. 1998. 1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation. Biophys. J. 74:422-429.
34. Stefani, M., N. Taddei, and G. Ramponi. 1997. Insights into acylphosphatase structure and catalytic mechanism. Cell. Mol. Life Sci. 53:141-151.
35. Hamada, D., F. Chili, J. I. Guijarro, M. Kataoka, N. Taddei, and C. M. Dobson. 2000. Evidence concerning rate-limiting steps in protein folding from the effects of trifluoroethanol. Nat. Struct. Biol. 7:58-61.
36. Matouschek, A., J. T. Kellis, Jr., L. Serrano, M. Bycroft, and A. R. Fersht. 1990. Transient folding intermediates characterized by protein engineering. Nature. 346:440-445.
37. Marcon, G., G. Plakoutsi, C. Canale, A. Relini, N. Taddei, C. M. Dobson, G. Ramponi, and F. Chiti. 2005. Amyloid formation from HypF-N under conditions in which the protein is initially in its native state. J. Mol. Biol. 347:323-335.
38. DuBay, K. F., A. P. Pawar, F. Chiti, J. Zurdo, C. M. Dobson, and M. Vendruscolo. 2004. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J. Mol. Biol. 341:1317-1326.
39. Chiti, F., M. Calamai, N. Taddei, M. Stefani, G. Ramponi, and C. M. Dobson. 2002. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc. Natl. Acad. Sci. USA. 99:16419-16426.
40. Dobson, C. M. 1999. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24:329-332.
41. Villegas, V., J. Zurdo, V. V. Filimonov, F. X. Aviles, C. M. Dobson, and L. Serrano. 2000. Protein engineering as a strategy to avoid formation of amyloid fibrils. Protein Sci. 9:1700-1708.
42. Ferrao-Gonzales, A. D., S. O. Souto, J. L. Silva, and D. Foguel. 2000. The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state. Proc. Natl. Acad. Sci. USA. 97:6445-6450.
43. McParland, V. J., N. M. Kad, A. P. Kalverda, A. Brown, P. Kirwin-Jones, M. G. Hunter, M. Sunde, and S. E. Radford. 2000. Partially unfolded states of β(2)-microglobulin and amyloid formation in vitro. Biochemistry. 39:8735-8746.
44. Chiti, R, N. Taddei, M. Bucciantini, P. White, G. Ramponi, and C. M. Dobson. 2000. Mutational analysis of the propensity for amyloid formation by a globular protein. EMBO J. 19:1441-1449.
45. Raffen, R., L. J. Dieckman, M. Szpunar, C. Wunschl, P. R. Pokkuluri, P. Dave, P. Wilkins Stevens, X. Cai, M. Schiffer, and F. J. Stevens. 1999. Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains. Protein Sci. 8:509-517.
46. Hammarstrom, P., X. Jiang, A. R. Hurshman, E. T. Powers, and J. W. Kelly. 2002. Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity. Proc. Natl. Acad. Sci. USA. 99:16427-16432.
47. Ramirez-Alvarado, M., J. S. Merkel, and L. Regan. 2000. A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc. Natl. Acad. Sci. USA. 97:8979-8984.
48. Calloni, G., S. Zoffoli, M. Stefani, C. M. Dobson, and F. Chiti. 2005. Investigating the effects of mutations on protein aggregation in the cell. J. Biol. Chem. 280:10607-10613.
49. Monti, M., B. L. Garolla di Bard, G. Calloni, F. Chiti, A. Amoresano, G. Ramponi, and P. Pucci. 2004. The regions of the sequence most exposed to the solvent within the amyloidogenic state of a protein initiate the aggregation process. J. Mol. Biol. 336:253-262.
50. Richardson, J. S., and D. C. Richardson. 2002. Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl. Acad. Sci. USA. 99:2754-2759.